Minerva Neurosciences Files 8-K
Ticker: NERV · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1598646
Sentiment: neutral
Topics: sec-filing, 8-k, routine-report
Related Tickers: MINV
TL;DR
MINV filed a routine 8-K, no major news.
AI Summary
Minerva Neurosciences, Inc. filed an 8-K on March 19, 2025, reporting an event that occurred on March 17, 2025. The filing is categorized under 'Other Events' and does not specify any significant financial transactions or corporate changes beyond the routine reporting requirement.
Why It Matters
This filing indicates routine corporate activity for Minerva Neurosciences, Inc. and does not appear to contain material new information for investors at this time.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose any new material information, risks, or significant corporate actions.
Key Players & Entities
- Minerva Neurosciences, Inc. (company) — Registrant
- 000-36517 (company) — Commission File Number
- 26-0784194 (company) — IRS Employer ID Number
- 1500 District Avenue, Burlington, MA 01803 (company) — Principal executive offices address
- March 17, 2025 (date) — Date of earliest event reported
- March 19, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report an event that occurred on March 17, 2025, under the 'Other Events' section, as required by the SEC.
What is the exact date of the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 17, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 1500 District Avenue, Burlington, MA 01803.
What is Minerva Neurosciences, Inc.'s Commission File Number?
Minerva Neurosciences, Inc.'s Commission File Number is 000-36517.
Does this filing indicate any specific material changes or transactions?
This filing is categorized under 'Other Events' and does not specify any particular material changes or transactions beyond the routine reporting requirement.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Minerva Neurosciences, Inc. (NERV).